RESCON 2023

Beth L. Laube received her Ph.D. from the Johns Hopkins Bloomberg School of Public Health and is currently Professor Emerita at the Johns Hopkins School of Medicine. Dr. Laube’s research is translational in nature and is centered on in vivo […]

Hugh D. C. Smyth is the Alcon Centennial Professor, College of Pharmacy, The University of Texas at Austin. Dr Smyth oversees and multidisciplinary laboratory funded through NIH, FDA, and industry that focuses on engineering new drug delivery systems with an […]

Dr. Smaldone received a Bachelors Degree in Chemical Engineering at New York University School of Engineering in 1969.  In 1975, he completed a combined M.D., Ph.D. Program at New York University School of Medicine.  His thesis was in pulmonary mechanics.  […]

Thomas Hofmann is the MannKind as Chief Scientific Officer since December 2020 when MannKind acquired Qrumpharma – a pharmaceutical company with focus on mycobacterial pulmonary disease that Thomas founded. He has spent more than 25 years as a clinical developer […]

Dr. Katharina Schwarz (f) leads the department “Aerosol Technology and Aerosol Biophysics” at the Fraunhofer Institute for Toxicology and Experimental Medicine (ITEM) in Hannover, Germany since 2015. She is an expert at the interface between aerosol/inhalation research, respiratory pharmacokinetics, toxicology/physiology […]

Philip Kuehl is a Senior Scientist and Senior Director of Scientific Core Laboratories at Lovelace Biomedical in Albuquerque, NM.  He holds a bachelor’s degree in biochemistry from Hamline University in St. Paul, MN and a PhD in Pharmaceutical Sciences from […]

Jeffry Weers is currently the Chief Technology Officer at cystetic Medicines, Inc. cystetic Medicines is focused on development of a novel genotype independent ion channel mimetic that restores anion transport in people with cystic fibrosis caused by Class 1 and […]

David is the VP of Research at Insmed Incorporated, where he is part of a team developing novel, targeted therapies to help serve the critical unmet needs of patients battling serious rare diseases. Prior to joining Insmed in 2018, David […]

Marian Asch has a BSc. degree in business and engineering from University of Stuttgart. He started his career as Project Manager in Harro Hoefligers Business Unit Inhalation in 2017. In this role he managed DPI projects of multinational pharma clients […]

Dr Vivek Gupta is an associate professor of industrial pharmacy at College of Pharmacy & Health Sciences. Dr Gupta’s is an experienced pharmaceutical researcher with interests in developing novel therapies for respiratory disorders. His expertise lies in the fields of […]